Iowa Patent of the Month – March 2024
Traditionally, aligning the optical axes of the subject’s eye and the imaging optics has been a complex and sometimes cumbersome task. It often required manual adjustments by trained operators or the use of robotic systems, both of which added significant cost and complexity to the imaging workflow. Digital Diagnostics, Inc saw an opportunity to simplify this process and reduce both the cost and complexity associated with ocular imaging alignment. The company has been granted a patent for their new approach to aligning the eye in ocular imaging.
Digital Diagnostics is an AI-based healthcare technology company set on improving healthcare by improving imaging techniques. Their invention, a device for aligning a subject’s eye with the optical axis of an ocular imaging device, is a game-changer in the field. At its core is a tubular housing that allows for the passage of the optical axis. Mounted around the luminal space are guide light assemblies, each equipped with a guide light and a baffle. These guide lights are strategically positioned to be visible to the subject only when their eye is in perfect alignment with the optical axis of the imaging device.
What sets this invention apart is its simplicity and efficiency. Gone are the days of manual adjustments or complex robotic systems. With Digital Diagnostics’ device, alignment becomes intuitive and effortless. The guide lights provide clear visual cues to both the subject and the operator, ensuring perfect alignment with minimal effort.
Digital Diagnostics’ ocular alignment system offers additional features such as adjustable baffles and indicator signals, further enhancing its versatility and usability. Whether aligning along the x, y, or z-axis, this system adapts to meet the unique needs of each imaging scenario.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
